Amgen files 8-K: Agreement Terminated
Amgen filed a Form 8-K with the SEC on Jan 30, 2026, 8:00 AM ET, reporting an event dated Jan 30, 2026. It covers Item 1.02 (Termination of a Material Definitive Agreement); Item 9.01 (Financial Statements and Exhibits).
- Form 8-K accepted by EDGAR Jan 30, 2026, 8:00 AM ET
- Item 1.02 (Termination of a Material Definitive Agreement)
- Item 9.01 (Financial Statements and Exhibits)
- Accession number 0001193125-26-030518
Source
SEC EDGARJan 30, 2026, 8:00 AM ET
SEC filing 8-K · accession 0001193125-26-030518 · sec.gov ↗